Public Joint-Stock Company "Pharmsynthez" (LIFE)
52 financial statements for Public Joint-Stock Company "Pharmsynthez" (LIFE), 2009 to 2026 — 18 IFRS and 34 RSBU, 9 verified line by line against the issuer's own filing. Balance sheet, income statement and cash flow, as filed.
- Statements held: 52
- Verified: 9
- Period covered: 2009–2026
- IFRS: 18 · RSBU: 34